Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Genetics

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 37 articles:
HTML format



Single Articles


    February 2021
  1. GOODMAN CW, Brett AS
    Race and Pharmacogenomics-Personalized Medicine or Misguided Practice?
    JAMA. 2021;325:625-626.
    PubMed    


    November 2020
  2. FEERO WG
    Bioinformatics, Sequencing Accuracy, and the Credibility of Clinical Genomics.
    JAMA. 2020;324:1945-1947.
    PubMed    


    August 2020
  3. RODGERS GP, Collins FS
    Precision Nutrition-the Answer to "What to Eat to Stay Healthy".
    JAMA. 2020 Aug 7. pii: 2769420. doi: 10.1001/jama.2020.13601.
    PubMed    


    June 2020
  4. RAYMOND FL
    Clinical Genomics in Critically Ill Infants and Children.
    JAMA. 2020;323:2480-2482.
    PubMed    


    April 2020
  5. FEERO WG, Wicklund CA
    Consumer Genomic Testing in 2020.
    JAMA. 2020;323:1445-1446.
    PubMed    


    January 2020
  6. KRIST AH, Owens DK, Mangione CM
    Recommendations Related to Genetic Testing for Breast Cancer-Reply.
    JAMA. 2020;323:188-189.
    PubMed    


  7. PINSKY PF
    Recommendations Related to Genetic Testing for Breast Cancer.
    JAMA. 2020;323:187-188.
    PubMed    


  8. DORK T, Park-Simon TW, Hillemanns P
    Recommendations Related to Genetic Testing for Breast Cancer.
    JAMA. 2020;323:188.
    PubMed    


    August 2019
  9. MILLER PG, Li G, Singal G
    PD-L1 Status and Survival in Patients With Lung Cancer-Reply.
    JAMA. 2019;322:783-784.
    PubMed    


  10. YANG X, Qi C, Ji M
    PD-L1 Status and Survival in Patients With Lung Cancer.
    JAMA. 2019;322:783.
    PubMed    


  11. DOMCHEK S, Robson M
    Broadening Criteria for BRCA1/2 Evaluation: Placing the USPSTF Recommendation in Context.
    JAMA. 2019;322:619-621.
    PubMed    


  12. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
    Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2019;322:652-665.
    PubMed     Abstract available


  13. NELSON HD, Pappas M, Cantor A, Haney E, et al
    Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019;322:666-685.
    PubMed     Abstract available


  14. JIN J
    Should I Be Tested for BRCA Mutations?
    JAMA. 2019;322:702.
    PubMed    


    April 2019
  15. BASCH E, Schrag D
    The Evolving Uses of "Real-World" Data.
    JAMA. 2019;321:1359-1360.
    PubMed    


  16. SINGAL G, Miller PG, Agarwala V, Li G, et al
    Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
    JAMA. 2019;321:1391-1399.
    PubMed     Abstract available


    March 2019
  17. GWINN M, MacCannell D, Armstrong GL
    Next-Generation Sequencing of Infectious Pathogens.
    JAMA. 2019;321:893-894.
    PubMed    


    February 2019
  18. MANDL KD, Manrai AK
    Potential Excessive Testing at Scale: Biomarkers, Genomics, and Machine Learning.
    JAMA. 2019;321:739-740.
    PubMed    


    October 2018
  19. BONHAM VL, Green ED, Perez-Stable EJ
    Examining How Race, Ethnicity, and Ancestry Data Are Used in Biomedical Research.
    JAMA. 2018;320:1533-1534.
    PubMed    


    August 2018
  20. PRESLEY CJ, Tang D, Soulos PR, Chiang AC, et al
    Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.
    JAMA. 2018;320:469-477.
    PubMed     Abstract available


    June 2018
  21. GILL J, Obley AJ, Prasad V
    Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
    JAMA. 2018;319:2377-2378.
    PubMed    


  22. PHILLIPS KA
    Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?
    JAMA. 2018;319:2379-2380.
    PubMed    


    April 2018
  23. OSTER AM, France AM, Mermin J
    Molecular Epidemiology and the Transformation of HIV Prevention.
    JAMA. 2018 Apr 9. pii: 2678246. doi: 10.1001/jama.2018.1513.
    PubMed    


    March 2018
  24. GAGE BF, Bass AR, Eby CS
    Genotype vs Clinically Guided Dosing of Warfarin to Prevent Adverse Events-Reply.
    JAMA. 2018;319:1279-1280.
    PubMed    


  25. HAN-YOU X
    Genotype vs Clinically Guided Dosing of Warfarin to Prevent Adverse Events.
    JAMA. 2018;319:1278-1279.
    PubMed    


    September 2017
  26. EMERY JD
    Pharmacogenomic Testing and Warfarin: What Evidence Has the GIFT Trial Provided?
    JAMA. 2017;318:1110-1112.
    PubMed    


    August 2017
  27. KUEHN BM
    Pilot Programs Seek to Integrate Genomic Data Into Practice.
    JAMA. 2017;318:410-412.
    PubMed    


    July 2017
  28. HAMPTON T
    Bench to Bedside and Back Again May Be Key to Clinical Breakthroughs.
    JAMA. 2017;318:16-17.
    PubMed    


  29. KHOURY MJ
    No Shortcuts on the Long Road to Evidence-Based Genomic Medicine.
    JAMA. 2017;318:27-28.
    PubMed    


    May 2017
  30. FEERO WG
    Introducing "Genomics and Precision Health".
    JAMA. 2017;317:1842-1843.
    PubMed    


  31. WEST KM, Blacksher E, Burke W
    Genomics, Health Disparities, and Missed Opportunities for the Nation's Research Agenda.
    JAMA. 2017;317:1831-1832.
    PubMed    


    April 2017
  32. SCHWARTZ MLB, Williams MS, Murray MF
    Adding Protective Genetic Variants to Clinical Reporting of Genomic Screening Results: Restoring Balance.
    JAMA. 2017;317:1527-1528.
    PubMed    


    February 2017
  33. KURIAN AW, Griffith KA, Hamilton AS, Ward KC, et al
    Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
    JAMA. 2017;317:531-534.
    PubMed    


    December 2016
  34. BUCHER K
    New Frontiers of Medical Illustration.
    JAMA. 2016;316:2340-2341.
    PubMed    


    November 2016
  35. ABBASI J
    Pioneering Geneticist Explains Ambitious Plan to "Write" the Human Genome.
    JAMA. 2016;316:2074-2076.
    PubMed    


    October 2016
  36. DZAU VJ, Ginsburg GS
    Realizing the Full Potential of Precision Medicine in Health and Health Care.
    JAMA. 2016;316:1659-1660.
    PubMed    


  37. ABBASI J
    Getting Pharmacogenomics Into the Clinic.
    JAMA. 2016;316:1533-1535.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Genetics is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: